近日，国家医保谈判现场吸引了众多药企的关注。这些药企在场外“踩点”，纷纷希望能够与国家医保局进行谈判，为自己的药品推广打开局面。
据了解，医保谈判现场的门票价格不菲，最高甚至达到了数万元。然而，仍有药企愿意花费重金进场，以期获得国家医保局的支持。
事实上，医保谈判对于药企来说非常重要。医保局每年都会进行药品目录的调整，以及医保支付标准的制定，这直接关系到药企的生存和发展。
因此，药企们纷纷将目光投向医保谈判，希望能够在现场加强与医保局沟通，为自己的药品争取更多的市场机会。
英文标题：Scandal at National Health Insurance Negotiation: Pharmaceutical Companies Try to “Stalk” the Scene
关键词：health insurance, pharmaceutical companies, negotiation
新闻内容：
Recently, the scene of the National Health Insurance negotiation has attracted the attention of many pharmaceutical companies. These companies are trying to “stalk” the scene, hoping to negotiate with the National Health Insurance Administration for promoting their drugs.
It is understood that the negotiation scene for the health insurance is of great importance to pharmaceutical companies. The National Health Insurance Administration 每年都会 adjust the drug 目录 and determine the payment standards, which directly affect the survival and development of pharmaceutical companies.
Therefore, pharmaceutical companies are paying close attention to the negotiation scene, hoping to strengthen their communication with the health insurance administration and secure more market opportunities for their drugs.
【来源】http://www.chinanews.com/cj/2023/11-18/10114031.shtml
Views: 1